In experiments using blood cells from human patients with diabetes and other autoimmune disorders, researchers have confirmed the mechanism behind a potential new therapy for type 1 diabetes.

Scientists showed that blocking a metabolic pathway regulating the immune system specifically eliminated immune cells that react against a patient's own tissues.